MML Investors Services
IMUX icon

MML Investors Services’s Immunic IMUX Stock Holding History

MML Investors Services’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Buy
14,662
+5,599
+62% +$69.1K ﹤0.01% 3018
2026
Q1 		$101K Buy
+9,063
New +$81.2K ﹤0.01% 2894

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

MML Investors Services's IMUX Position: Q2 2026 in Review

MML Investors Services increased its Immunic (IMUX) stake by 62% in Q2 2026, buying an estimated $69.1K and bringing the position to 14,662 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #3018.

MML Investors Services first reported a position in IMUX in Q1 2026 and has held it in 2 quarters since. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • MML Investors Services held 14,662 shares of Immunic worth $225K as of Q2 2026.
  • MML Investors Services bought 5,599 Immunic shares in Q2 2026, an estimated $69.1K.
  • Immunic made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #3018 holding.
  • MML Investors Services first reported a position in Immunic in Q1 2026 and has held it in 2 quarters since.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.